title: Methotrexate hepatotoxicity: what is the evidence?
authors.affiliation: Department of Medicine and Immunology, Flinders University of South Australia, Bedford Park. sahermj@rgh.sa.gov.au
authors.forename: M J
authors.initials: MJ
authors.lastname: Ahern
authors.forename: M D
authors.initials: MD
authors.lastname: Smith
authors.forename: P J
authors.initials: PJ
authors.lastname: Roberts-Thomson
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced; D008111:Liver Function Tests; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy; D018570:Risk Assessment
chemical_list: D018501:Antirheumatic Agents; D003879:Dermatologic Agents; D008727:Methotrexate